Peregrine Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.54M | Buy |
|
|||||
|
2025
Q2 | $5.8M | Buy |
|
|||||
|
2025
Q1 | $7.43M | Buy |
|
|||||
|
2024
Q4 | $8.29M | Buy |
|
|||||
|
2024
Q3 | $7.95M | Sell |
|
|||||
|
2024
Q2 | $8.06M | Buy |
|
|||||
|
2024
Q1 | $8.64M | Buy |
|
|||||
|
2023
Q4 | $8.59M | Sell |
|
|||||
|
2023
Q3 | $8.86M | Buy |
|
|||||
|
2023
Q2 | $8.91M | Sell |
|
|||||
|
2023
Q1 | $8.83M | Buy |
|
|||||
|
2022
Q4 | $8.59M | Sell |
|
|||||
|
2022
Q3 | $8.48M | Buy |
|
|||||
|
2022
Q2 | $8.38M | Sell |
|
|||||
|
2022
Q1 | $7.83M | Sell |
|
|||||
|
2021
Q4 | $10.1M | Buy |
|
|||||
|
2021
Q3 | $6.78M | Sell |
|
|||||
|
2021
Q2 | $6.95M | Buy |
|
|||||
|
2021
Q1 | $6.82M | Buy |
|
|||||
|
2020
Q4 | $15.5M | Sell |
|
|||||
|
2020
Q3 | $13.9M | Sell |
|
|||||
|
2020
Q2 | $14.9M | Sell |
|
|||||
|
2020
Q1 | $11.6M | Buy |
|
|||||
|
2019
Q4 | $12.2M | Buy |
|